SuperworthTraws Pharma shares outstanding TRAW
Diluted shares outstanding, averaged over each quarter, from 2012.
- Latest quarter, to Jun 30, 2026
- 15.9M
- On a year earlier
- +172.5%
- more shares
Traws Pharma had 15.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 172.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 9.3M | +205% |
| FY2024 | 3.1M | +265% |
| FY2023 | 840.5K | +0% |
| FY2022 | 837K | +0% |
| FY2021 | 835.7K | +69% |
| FY2020 | 493.8K | +371% |
| FY2019 | 104.7K | +592% |
| FY2018 | 15.1K | +724% |
| FY2017 | 1.8K | +53% |
| FY2016 | 1.2K | +171% |
| FY2015 | 443 | +15% |
| FY2014 | 386 | +1% |
| FY2013 | 381 | +829% |
| FY2012 | 41 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 15.9M | +173% | |
| Q1 FY26 | 10.6M | +47% | |
| Q4 FY25 | 9.3M | +205% | |
| Q3 FY25 | 8.8M | +817% | |
| Q2 FY25 | 5.8M | +475% | |
| Q1 FY25 | 7.2M | +757% | |
| Q4 FY24 | 3.1M | +265% | |
| Q3 FY24 | 961.5K | +14% | |
| Q2 FY24 | 1M | +21% | |
| Q1 FY24 | 841.7K | +0% | |
| Q4 FY23 | 840.5K | +0% | |
| Q3 FY23 | 840.1K | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Traws Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.